Atossa stockholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting

ATOSSA THERAPEUTICS, INC.

Class I directors Steven C. Quay (28.4M for, 4.2M withheld) and Jonathan F. Finn (30.2M for, 2.4M withheld) elected.
Ratification of Ernst & Young as auditor passed with 55.8M for, 6.7M against, 1.4M abstain.
Non-binding advisory vote on executive compensation approved with 25.6M for, 6.5M against, 0.5M abstain.
Stockholders selected one-year frequency for future say-on-pay votes (29.3M votes for 1 year).
Record date March 20, 2025; 129,170,004 shares entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.